Spatiotemporal trajectories and socioeconomic inequities in mortality from oesophageal and pancreatic cancers
| Oesophageal cancer mortality | Pancreatic cancer mortality | |||
|---|---|---|---|---|
| Model 1 | Model 2 | Model 1 | Model 2 | |
| Fixed part | Rate ratio (95% CI) | |||
| Year | 0.98 (0.95 to 1.00) | 0.96 (0.93 to 0.99) | 1.04 (1.01 to 1.08) | 1.06 (1.02 to 1.10) |
| Year2 | 1.00 (0.99 to 1.00) | 1.00 (0.99 to 1.00) | 1.00 (0.99 to 1.00) | 0.99 (0.99 to 1.00) |
| Gender (ref: male) | ||||
| Female | 0.20 (0.19 to 0.21) | 0.23 (0.21 to 0.24) | 0.59 (0.55 to 0.64) | 0.59 (0.55 to 0.64) |
| Age group (ref: 50–59 years) | ||||
| 60–69 | 2.38 (2.28 to 2.49) | 2.44 (2.31 to 2.56) | 2.26 (2.12 to 2.42) | 2.27 (2.13 to 2.41) |
| 70–79 | 4.67 (4.47 to 4.87) | 4.84 (4.60 to 5.09) | 4.59 (4.30 to 4.89) | 4.56 (4.29 to 4.86) |
| 80+ | 6.85 (6.52 to 7.19) | 7.10 (6.72 to 7.50) | 6.01 (5.55 to 6.50) | 5.91 (5.48 to 6.36) |
| Gender×age group (years) | ||||
| Female×60–69 | 1.42 (1.31 to 1.54) | 1.39 (1.28 to 1.52) | 1.14 (1.02 to 1.26) | 1.13 (1.02 to 1.25) |
| Female×70–79 | 1.81 (1.67 to 1.95) | 1.72 (1.58 to 1.88) | 1.27 (1.15 to 1.41) | 1.26 (1.14 to 1.39) |
| Female×80+ | 2.06 (1.89 to 2.24) | 1.88 (1.71 to 2.06) | 1.26 (1.12 to 1.42) | 1.26 (1.12 to 1.40) |
| Mean years of education | 0.87 (0.77 to 0.98) | 1.34 (1.25 to 1.44) | ||
| Year×Mean years of education | 0.97 (0.95 to 0.99) | 0.98 (0.96 to 1.00) | ||
| Year2×Mean years of education | 1.00 (1.00 to 1.01) | 1.00 (1.00 to 1.01) | ||
| Random part | ||||
| DSP×Year | ||||
| Intercept variance (SE) [MOR] | 1.131 (0.133) [2.76] | 1.189 (0.139) [2.83] | 0.488 (0.066) [1.95] | 0.343 (0.049) [1.75] |
| Covariance (SE) | −0.024 (0.017) | −0.022 (0.016) | −0.027 (0.015) | −0.007 (0.012) |
| Slope variance (SE) | 0.008 (0.003) | 0.003 (0.004) | 0.003 (0.005) | 0.002 (0.005) |
DSP, disease surveillance point; MRR, median rate ratio.